Portfolio
Bingli
Digital HealthThe smartest medical interview
Bingli
BlueBee
Digital HealthCutting-edge digital technology to drastically accelerate DNA processing and analysis.
BlueBee
Cartagenia
Digital HealthSoftware solutions for genetic diagnosis
Cartagenia
Confo Therapeutics
Pharma & BiotechStabilize, target, discover and transform
Confo Therapeutics
DEO.care
Digital HealthData-Driven Efficiency for the Operating Room
DEO.care
Diagenode
DiagnosticsLeading molecular diagnostics
Diagenode
FEops
Digital HealthTransforming cardiac images into digital twins
FEops
Icometrix
Digital HealthTransforming patient care through AI-driven imaging
Icometrix
Indigo Diabetes
Digital HealthGlucose-monitoring sensors
Indigo Diabetes
Mainstay Medical
Medical DevicesRehabilitative treatment for severe low back pain
Mainstay Medical
Minze
Digital HealthUroflowmetry and bladder diaries reinvented
Minze
Neotiv
Digital HealthEnabling cognitive health
Neotiv
Noona
Digital HealthEngaging cancer patients in their care
Noona
Ogeda
Pharma & BiotechClinical-stage drug discovery
Ogeda
exited
Sector
Pharma & Biotech
Headquarters
Belgium
Portfolio entry
2016: Capricorn Healthtech Fund I
Exit
2017
Clinical-stage drug discovery
Ogeda is a drug development company with a chemistry service business focusing on discovery of small molecules targeting GPCRs. The companies’ lead program for the non-hormonal treatment of hot flashes is addressing a huge issue for woman worldwide and attracted the attention of Japanese based Astellas
The investment illustrates the fund’s belief that purpose-driven R&D companies within healthcare are critical for developing novel solutions to improve the quality of life of people. The company was successfully sold to Astellas for a purchase price of €500 million plus milestones.
Sequana Medical
Medical DevicesInnovative treatments for fluid overload
Sequana Medical
Thryve
Digital HealthShaping the Future of Personalized Health
Thryve
iSTAR Medical
Medical DevicesImplants for patients with glaucoma